Brooklyn ImmunoTherapeutics (BTX) – Major News
-
BioTime (BTX) Misses Q2 EPS by 15c
-
BioTime (BTX) Tops Q1 EPS
-
BioTime (BTX) Reports Q4 Loss of $0.35/Share
-
BioTime (BTX) Names Brian Culley as CEO
-
BioTime (BTX) Tops Q2 EPS by 5c
-
BioTime (BTX) Misses Q1 EPS by 43c
-
BioTime (BTX) Reports Q4 Loss of $0.58/Share
-
BioTime (BTX) Misses Q3 EPS by 3c
-
BioTime (BTX) Misses Q2 EPS by 3c
-
BioTime (BTX) Tops Q1 EPS by 55c
-
BioTime (BTX) Tops Q4 EPS by 9c
-
BioTime (BTX) Posts Q3 EPS of 30c
-
BioTime (BTX) Reports Q2 EPS of $0.26
-
BioTime (BTX) Misses Q1 EPS by 5c
-
BioTime (BTX) Reports Q1 Loss of $0.13/Share
-
BioTime (BTX) Reports Q3 Loss of $0.12/Share
-
BioTime, Inc. (BTX) Reports Q2 Loss of $0.16/Share
-
BioTime, Inc. (BTX) Narrows Q1 Loss
-
BioTime, Inc. (BTX) Widens Q3 Loss to 16c/Share
-
BioTime, Inc. (BTX) Widens Q4 Loss to 12c/Share
-
BioTime, Inc. (BTX) Widens Q1 Loss to 10c/Share
-
BioTime, Inc. (BTX) Reports Q4 Loss of $0.10
-
BioTime, Inc. (BTX) Reports Q3 Loss of $0.08
-
BioTime, Inc. (BTX) Reports Q2 Loss of $0.09
-
BioTime, Inc. (BTX) Swings to Q4 Loss
-
BioTime (BTX) Post Q3 Loss Remained Flat; Revs Nearly Double
Back to BTX Stock Lookup